Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment

ConditionsHealthy IBS - Irritable Bowel Syndrome Inflammatory Bowel Diseases

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-100

SponsorStanford University

About this trial

GI disorders are influenced by the gut microbiome. To date, sampling of the small intestine in GI disorders has been limited. The investigators plan to sample the small intestinal contents during endoscopy for research purposes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age >18years

Patients seen at Stanford University Digestive Health Center who are scheduled for an upper endoscopy as part of their Standard Of Care

Disqualifiers

None

Trial population

Patients seen at Stanford University Digestive Health Center who are scheduled for an upper endoscopy as part of their Standard Of Care

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

endoscopic sampling of luminal fluid
Other intervention
We will collect luminal fluid via endoscopic sampling

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

Ability to isolate live bacteria from 95% of samples

We aim to isolate live bacteria from 95% of samples

Time frame

1-4 years

Secondary outcomes

Ability to measure quantitative Colony Forming Units (CFUs) in 90% of samples

We aim to measure quantitative Colony Forming Units (CFUs) in 90% of samples

Time frame

1-4 years

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Stanford University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: